Articles

Barry Diller’s $12.4 billion offer for MGM is a big bet that Vegas is back

Las Vegas has suffered from uneven tourism trends as well as sports-betting competition, but analysts say there’s reason to believe things are looking up for Sin City.

Did Trump spark an IBM stock rally? It’s complicated.

IBM’s strong stock momentum Monday comes as the software sector continues its comeback.

Wall Street keeps its AI stock-picking secrets — here’s what robo advisers actually do

AI financial advisers aren’t the brilliant investors you’d expect.

Microsoft’s stock chart just flashed a bullish signal for a software comeback

Software stocks are shaking off AI jitters as Microsoft shares break above their 200-day moving average.

YouTube is now Hollywood’s horror-film pipeline — and the new model for movie making

The box-office bonanza over the weekend of YouTube-generated horror films “Backrooms” and “Obsession” is being viewed as a possible sea-change moment for Tinseltown.

Anthropic just set the stage for a blockbuster IPO — beating OpenAI to the punch

SpaceX is gearing up for its listing and OpenAI is expected to soon file confidentially for its own IPO.

Strategy’s stock drops after rare bitcoin sale tests ‘never sell’ narrative

Strategy’s stock slid Monday after the company disclosed a rare bitcoin sale, rattling investors who have long treated the company as a one-way bet on the cryptocurrency.

SpaceX says it will reserve 5% of its IPO shares for staff, friends and family

In a new filing, the company also clarified the nature of its multibillion-dollar deal with rival Anthropic.

U.S. manufacturers extend best hot streak since 2022, so why aren’t business leaders happy?

American manufacturers grew in May for the fifth month in a row — the biggest winning streak in four years — but lingering anxiety about the Trump tariffs and a rise in inflation tied to the Iran war left business leaders anxious.

The massive run-up in AI stocks this year may be built on a ‘token mirage’

Trading veteran Kevin Muir, author of the Macro Tourist on Substack, raises questions about true demand for artificial intelligence.

ServiceNow, Adobe stocks jump as Nvidia’s new AI chip sparks software rally

As AI agents spur demand for more software — not less — major enterprise cloud platforms are staging a comeback.

An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.

The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug
1 73 74 75 76 77 2,688